Healthcare stocks were ending narrowly mixed with the NYSE
Healthcare Sector Index advancing about 0.1% and shares of
healthcare companies in the S&P 500 sinking less than 0.1% as a
In company news, Cancer Genetics Inc. (
) advanced Wednesday after the National Institutes of Health added
the company's genomic-diagnostic tests to its Genetic Testing
Inclusion on the registry extends access to a broader audience
of clinicians, oncologists, patients and other biopharma companies
to information about CGIX's proprietary genomic tests as well as
its non-proprietary test offerings, it said.
CGIX shares were up more about 7.3% at $9.39 each, well off
their session high of $10.24 a share earlier today. The stock has
traded within a 52-week range of $8.48 to $23.25 a share, falling
nearly 11% over the past 12 months.
In other sector news,
(+) BSPM, Hires Xiaohui Zheng - currently a professor and the
director of the Engineering Research Center for the modernization
of Chinese herbal medicine at Northwestern University - as its
chief scientist and guiding its product development.
(-) ALNY, U.S. Patent and Trademark Office issues Notice of
Allowance for the company's patent application for compositions
using a double-stranded molecule of between 19 and 52 nucleotides
in each strand.